Now Enrolling: Chikungunya Virus Vaccine Clinical Trial

ABOUT US

SERVICES
CONTACT US

Call now, or fill out the form below, for more information.

727-768-5893 Mon – Fri 8am-8pm
727-768-2193 After-hours

Chikungunya Virus Vaccine Clinical Trial
First
Last

Chikungunya Vaccine Study

  • Chikungunya is a virus that can be spread through mosquito bites similar to other mosquito-spread illnesses like Zika, malaria, dengue, and West Nile Virus. GCP Research is conducting a study to test the effectiveness of a phase 3 vaccine to prevent Chikungunya in people who are 65 or older. The study will be 7 months long and consists of 5 office visits and 2 phone call appointments.
  • Ages: 65+
  • Compensation: $900*
  • Study Topic: Chikungunya Virus

*Compensation for time and travel may be available to those who qualify.